Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 11, 1999, Pages 865-869

  Flora, Swaran J S ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Arsenic; Brain; Combined treatment; Dimercaptosuccinic acid; Erythrocytes; Hepatic; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ARSENITE SODIUM; GLUTATHIONE; MALONALDEHYDE; PORPHOBILINOGEN SYNTHASE; SUCCIMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; INTOXICATION; LIVER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; RAT;

3,4-METHYLENEDIOXYAMPHETAMINE; 5-AMINOLEVULINATE SYNTHETASE; ACETYLCYSTEINE; ANIMALS; ARSENIC POISONING; BRAIN; CHELATING AGENTS; ERYTHROCYTES; FREE RADICAL SCAVENGERS; GLUTATHIONE; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUCCIMER;

EID: 0032693563     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03157.x     Document Type: Article

References (32)

1. 1. Fishbein L. Sources, transport and alteration of metal compounds: An overview. Arsenic, beryllium, cadmium, chromium and nickel. Environ. Health Perspect. 1981; 40: 43-64.
2. 2. Cantor KP. Arsenic in drinking water: How much is too much? Epidemiology 1996; 7: 113-15.
3. 3. Gonzalo GG, Mariano CE. Health effects of arsenic. In: Chang LW (ed.). Toxicology of Metals. CRC Press, Boca Raton. 1996; 487-504.
4. 4. Dreosti I. Free radical pathology and the genome. In: Dreosti IE (ed.). Trace Elements, Micronutrients and Free Radicals. Humana Press, Totowa, NJ. 1991; 149-68.
5. 5. Tabacova S, Baird DD, Balabaeva L, Lolova D, Petrov I. Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smeller area. Placenta 1994; 15: 873-81.
6. 6. Tripathi N, Flora SJS. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice. Biomed. Environ. Sci. 1998; 11: 38-45.
7. 7. Moldeus P, Cotgreave IA. N-acetyleysteine. Methods Enzymol. 1994; 234: 482-92.
8. 8. Gurer H, Ozgunes H, Neal R, Spitz DR, Ercal N. Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead exposed rats. Toxicology 1998; 128: 181-9.
9. 9. Arouma OT, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine in reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad. Biol. Med. 1989; 6: 593-7.
10. 10. Banner W, Koch M, Capin DM, Hopf SB, Chang S, Tong TG. Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetyleysteine and other compounds. Toxicol. Appl. Pharmacol. 1986; 83: 142-7.
11. 11. Ziment I. Acetylcysteine: a drug with an interesting past and a fascinating future. Resp. 1986; 50: 5-12.
12. 12. Angle CR. Childhood lead poisoning and its treatment. Annu. Rev. Pharmacol. Toxicol. 1993; 32: 409-34.
13. 13. Ercal N, Teeratphan P, Hammond TC, Matthews RH, Granneman NH, Spitz DR. In vivo indices of oxidative stress in lead exposed C57BL/6 mice are reduced by treatment with meso 2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Rad. Biol. Med. 1996; 15: 157-61.
14. 14. Flora SJS, Bhattacharya R, Vijyaraghavan R. Combined therapeutic potential of meso 2,3-dimercaptosuccinic acid and calcium disodium edetate in the mobilization and distribution of lead in experimental lead intoxication in rats. Fund. Appl. Toxicol. 1995; 25: 233-40.
15. 15. Flora SJS, Tripathi N. Treatment of arsenic poisoning: An update. Indian J. Pharmacol. 1998; 30: 209-17.
16. 16. Tripathi N, Kannan GM, Pant BP, Jaiswal DK, Malhotra PR, Flora SJS. Arsenic induced changes in certain neurotransmitter levels and their recoveries following chelation in rat whole brain. Toxicol. Lett. 1997; 92: 201-8.
17. 17. Muckter H, Liebl B, Reichl FX, Hunder G, Walther U, Fichtl B. Are we ready to replace dimercaptol (BAL) as an antidote? Hum. Exp. Toxicol. 1998; 16: 460-5.
18. 18. Flora SJS, Pant SC, Malhotra PR, Kannan GM. Biochemical and histopathological changes in arsenic intoxicated rats co-exposed to ethanol. Alcohol 1997; 14: 563-8.
19. 19. Itoh T, Zhang YF, Murai S et al. The effects of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol. Lett. 1990; 54: 345-53.
20. 20. Iffland R. Arsenic. In: Seiler D, Hans G, Siegel H (eds). Handbook on Metals in Clinical and Analytical Chemistry. Marcel Dekker Inc., New York. 1994; 237-52.
21. 21. Garcia Vargas GG, Cebrian ME. Health effects of arsenic. In: Chang LW (ed.). Toxicology of Metals. CRC Lewis Publ., New York. 1996; 423-8.
22. 22. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1973; 74: 214-26.
23. 23. Wilber KM, Baerheim F, Shapiro OW. The thiobarbituric acid reagent as a test for the oxidation of unsaturated fatty acid by various reagents. Arch. Biochem. Biophys. 1949; 24: 304-11.
24. 24. Stocks J, Dormandy TL. Auto-oxidation of red cell lipids induced by hydrogen peroxide. Br. J. Haematol. 1971; 20: 95-111.
25. 25. Berlin A, Schaller KH. European standardized method for the determination of delta aminolevulinic acid dehydratase activity in blood. Z. Klin. Chem. Klin. Biochem. 1974; 12: 389-90.
26. 26. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265-76.
27. 27. Clegg JW, King KJ. Estimation of haemoglobin by the alkaline haematin method. BMJ 1942; 2: 329-33.
28. 28. Forst HT Probleme des multiplen testen und Schatzen in der Arzneimittel forchung. Arzneimittelforschung 1985; 35.
29. 29. Lenz K, Hruby K, Druml W et al. 2,3-Dimercaptosuccinic acid in human arsenic poisoning. Arch. Toxicol. 1981; 47: 241-3.
30. 30. Kreppel H, Pepcke U, Thierman H, Szinicz L, Reichl FX, Singh PK. Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxidc poisoning in mice. Arch. Toxicol. 1993; 67: 580-5.
31. 31. Martin DS, Willis SE, Cline DM. N-Acetylcysteine in the treatment of human arsenic poisoning. J. Am. Board Fam. Pract. 1990; 3: 293-6.
32. 32. Benov LC, Benchev IC, Monovich OH. Thiol antidotes effects on lipid peroxidation in mercury poisoned rats. Chem. Biol. Interact. 1990; 76: 321-32.